Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

4,233 studies for “Alzheimer disease”

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationRecruiting
NCT05552157Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Canada, Colombia +10 more
Effect and Safety of Non-invasive Electrical Stimulation in Alzheimer's DiseaseEnrolling By Invitation
NCT07694921NAUpdated Jul 27, 2026
Sponsor: First Affiliated Hospital of Zhejiang University
Alzheimer's Disease(AD)
China
Community-based Brain Health Program to Address Dementia RiskCompleted
NCT05529706NAUpdated Jul 27, 2026
Sponsor: Posit Science Corporation
Dementia · Alzheimer Disease
United States
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)Recruiting
NCT07169630Phase 1Updated Jul 27, 2026
Sponsor: National Institute of Mental Health (NIMH)
Alzheimer s Disease · Mild Cognitive Impairment · Healthy
United States
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001Active Not Recruiting
NCT01760005Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Brazil, Canada +10 more
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationRecruiting
NCT06647498Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Canada, Colombia +10 more
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)Active Not Recruiting
NCT05269394Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Brazil, Canada +11 more
Ozanimod in Patients With Alzheimer's DiseaseRecruiting
NCT06862960Phase 2Updated Jul 27, 2026
Sponsor: ChenXiaoChun
Alzheimer Disease
China
Amyloid PET Imaging in the Baltimore Longitudinal Study of AgingRecruiting
NCT07099053N/AUpdated Jul 27, 2026
Sponsor: National Institute on Aging (NIA)
Aging
United States
DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's DiseaseActive Not Recruiting
NCT06384573Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimer's Disease · Dementia · Alzheimer's Disease, Familial
United States, Australia, United Kingdom
COMMETS- Combination MCI Metabolic SyndromeRecruiting
NCT06072963Phase 2Updated Jul 27, 2026
Sponsor: Rutgers, The State University of New Jersey
Alzheimer Disease · Mild Cognitive Impairment · Metabolic Syndrome
Israel
A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)Completed
NCT04867616Phase 2Updated Jul 24, 2026
Sponsor: UCB Biopharma SRL
Alzheimer's Disease
United States, Belgium, Canada, France, Germany +5 more
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's TypeRecruiting
NCT06052254Phase 2Updated Jul 24, 2026
Sponsor: Teikoku Pharma USA, Inc.
Agitation
United States
Neuroplasticity Enhancement From Cognitive Training Reinforced by PsilocybinNot Yet Recruiting
NCT07721467Phase 2Updated Jul 24, 2026
Sponsor: National Institute on Aging (NIA)
Alzheimer's Disease
United States
Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application TrialRecruiting
NCT07213284NAUpdated Jul 24, 2026
Sponsor: Michigan State University
Pregnancy · Pregnancy, Complications · Pregnancy Outcomes
United States
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesRecruiting
NCT07177352Phase 3Updated Jul 24, 2026
Sponsor: Hoffmann-La Roche
Alzheimers Disease
United States, Argentina, Australia, Brazil, Canada +9 more
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's DiseaseRecruiting
NCT06540833Phase 2Updated Jul 24, 2026
Sponsor: Intra-Cellular Therapies, Inc.
Psychosis Associated With Alzheimer's Disease
United States, Bulgaria, Croatia, Czechia, Poland +4 more
Enhancing Shared Decision-making to Guide Care for People With Dementia and DiabetesRecruiting
NCT05643144NAUpdated Jul 24, 2026
Sponsor: Indiana University
Diabetes · Alzheimer's Disease (Incl Subtypes) · Dementia · Hypoglycemia
United States
ACP-204 in Adults With Alzheimer's Disease PsychosisRecruiting
NCT06159673Phase 2, Phase 3Updated Jul 24, 2026
Sponsor: ACADIA Pharmaceuticals Inc.
Alzheimer's Disease Psychosis
United States, Brazil, Bulgaria, Chile, Czechia +7 more
Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's DiseaseCompleted
NCT02947893Phase 2Updated Jul 23, 2026
Sponsor: Georgetown University
Alzheimer's Disease
United States
An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's DiseaseRecruiting
NCT07724132Phase 3Updated Jul 23, 2026
Sponsor: University College, London
Alzheimer's Disease (AD) · Mild Cognitive Impairment Due to Alzheimer's Disease · Alzheimer Disease Dementia
United Kingdom
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's DementiaRecruiting
NCT06651567Phase 2Updated Jul 23, 2026
Sponsor: Intra-Cellular Therapies, Inc.
Agitation Associated With Alzheimer's Dementia
United States, Bulgaria, Croatia, Czechia, Romania +3 more
A Study to Evaluate ALN-5288 in Patients With Alzheimer's DiseaseRecruiting
NCT07214727Phase 1Updated Jul 23, 2026
Sponsor: Alnylam Pharmaceuticals
Alzheimer's Disease
Canada, Netherlands, Spain, United Kingdom
Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including People With Mild Cognitive Impairment and Dementia as Well as Their Family CaregiversRecruiting
NCT07721701N/AUpdated Jul 23, 2026
Sponsor: University of Erlangen-Nürnberg Medical School
Mild Cognitive Disorder · Alzheimer Disease · Vascular Dementia · Dementia in Other Diseases Classified Elsewhere
Germany
A Retrospective Database Study for the Development and Validation of Algorithms for Intracerebral Hemorrhage and Seizures in Alzheimer's DiseaseNot Yet Recruiting
NCT07723950N/AUpdated Jul 23, 2026
Sponsor: Eisai Inc.
Alzheimer's Disease

4,233 studies found